Syllabus for Immune, Gene and Cell Therapy

Immun-, gen- och cellterapi

Syllabus

  • 7.5 credits
  • Course code: 3MG018
  • Education cycle: Second cycle
  • Main field(s) of study and in-depth level: Medical Science A1N

    Explanation of codes

    The code indicates the education cycle and in-depth level of the course in relation to other courses within the same main field of study according to the requirements for general degrees:

    First cycle

    • G1N: has only upper-secondary level entry requirements
    • G1F: has less than 60 credits in first-cycle course/s as entry requirements
    • G1E: contains specially designed degree project for Higher Education Diploma
    • G2F: has at least 60 credits in first-cycle course/s as entry requirements
    • G2E: has at least 60 credits in first-cycle course/s as entry requirements, contains degree project for Bachelor of Arts/Bachelor of Science
    • GXX: in-depth level of the course cannot be classified

    Second cycle

    • A1N: has only first-cycle course/s as entry requirements
    • A1F: has second-cycle course/s as entry requirements
    • A1E: contains degree project for Master of Arts/Master of Science (60 credits)
    • A2E: contains degree project for Master of Arts/Master of Science (120 credits)
    • AXX: in-depth level of the course cannot be classified

  • Grading system: Fail (U), Pass (G)
  • Established: 2011-11-29
  • Established by: The Educational Board of Medicine/Chair
  • Revised: 2017-12-12
  • Revised by: The Educational Board of Medicine
  • Applies from: Autumn 2017
  • Entry requirements:

    120 credits in medicine, biomedicine, biology, pharmacy or biomedical laboratory science

  • Responsible department: Department of Immunology, Genetics and Pathology

Decisions and guidelines

Requirements.

At least 120 credits within medicine, biomedicine, biomedical laboratory science, pharmacy, biology or equivalent.

Learning outcomes

Knowledge and understanding

After the course the student should

  • be able to provide examples of diseases that can be treated with immune therapy, gene therapy and cell therapy.
  • be able to explain some of the roles the immune system play in cancer, in immune-mediated diseases such as allergy and autoimmunity and in transplantation.
  • be able to give examples and explain different technologies used in immune therapy, gene therapy and cell therapy.

Skills and abilities

After the course the student should

  • have shown ability to read, and evaluate scientific articles within the subjects of immune therapy, gene therapy and cell therapy.
  • proven ability to independently write an essay in the form of a short review article focused on a topic of their own choice that should apply to either immune, gene or cell therapy.

Evaluation and Synthesis

  • have shown ability to identify knowledge gaps and need for further research within their chosen topic of immune therapy, gene therapy or cell therapy.
  • demonstrated the ability to critically discuss and reflect on ethical and social aspects of using immune, gene or cell therapy.

Content

The course gives an overview of new and established treatments based on immune, gene and cell therapy. The course will discuss new opportunities as well as difficulties with these therapies. Examples of areas that will be presented are allergy, transplantation of endocrine cells, immunotherapy and cancer.

Instruction

The course is a lecture series with one introduction lecture and 10 research lectures. The lectures will be held by scientists and/or medical doctors in the field. The lectures will be held in English.

Assessment

1. Home exam with questions around the topics presented during the course (3 credits).

2. Independent work in the form of a written essay (review article) within the subject immune, gene and cell therapy (4.5 credits).

If there are special reasons for doing so, an examiner may make an exception from the method of assessment indicated and allow a student to be assessed by another method. An example of special reasons might be a certificate regarding special pedagogical support from the University's disability coordinator.

Other directives

Course leader: Maria Ulvmar PhD, 0737834297 och Karin Fromell PhD.

Syllabus Revisions

Reading list

Reading list

Applies from: Autumn 2022

Some titles may be available electronically through the University library.

Reading list

Literature for the course will be provided by lecturers during the course in form of research articles.

Print syllabus and reading list
Print